Valeant Pharmaceuticals International, Inc. (VRX.TO)

Toronto - Toronto Delayed Price. Currency in CAD
29.48+0.57 (+1.97%)
As of 1:49 PM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close28.91
Bid29.48 x
Ask29.49 x
Day's Range28.80 - 30.17
52wk Range24.32 - 167.30
1y Target EstN/A
Market Cap10.27B
P/E Ratio (ttm)-10.04
Avg Vol (3m)1,048,222
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
  • Here’s Why Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX), and Three Other Stocks Are in Spotlight
    Insider Monkey5 hours ago

    Here’s Why Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX), and Three Other Stocks Are in Spotlight

    Although several major companies have recently reported earnings, shares of five other companies, Clayton Williams Energy, Inc. (NYSE:CWEI), Netflix, Inc. (NASDAQ:NFLX), Tesla Motors Inc (NASDAQ:TSLA), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and SAExploration Holdings, Inc. (NASDAQ:SAEX), are trending for various reasons. In this article, let’s examine the reasons each stock is in the spotlight and see how […]

  • Barrons.com23 hours ago

    Valeant Pharmaceuticals: Bill Miller Isn't Following JPMorgan's Advice

    Earlier today, we noted that JPMorgan had warned clients to avoid Valeant Pharmaceuticals International (VRX) ahead of its earnings. In an appearance on CNBC, however, Legg Mason fund manager Bill Miller argued that Valeant's shares could double in three years. From Bloomberg: Bill Miller, who is best known for beating the S&P 500 Index for 15 straight years, says he has been buying Valeant Pharmaceuticals International Inc. and financial stocks such as OneMain Holdings Inc (OMF).

  • TheStreet.comyesterday

    Valeant (VRX) Stock Down, JPMorgan: Avoid Before Q3 Results

    JPMorgan expects Valeant (VRX) to cut its 2016 full-year earnings guidance and said it is 'cautious' on the stock.